Abstract
In this issue of Blood, Thompson et al present their exciting long-Term results with the use of fludarabine, cyclophosphamide, and rituximab (FCR) chemoimmunotherapy in patients with previously untreated chronic lymphocytic leukemia (CLL).1.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 274 |
| Number of pages | 1 |
| Journal | Blood |
| Volume | 127 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 21 2016 |
| Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology